Pharmaceutical

Pieris Pharma lays off 70% of workforce amid company restructuring

The biotech announced its employee cuts as part of a strategic update partly caused by the termination of its AstraZeneca collaboration.

Jul 19, 2023 - 20:00
Pieris Pharma lays off 70% of workforce amid company restructuring
The biotech announced its employee cuts as part of a strategic update partly caused by the termination of its AstraZeneca collaboration.
Read the original article

Tags:

Previous Article

STAT+: Key House panel plots a new health care package — complicating the chambe...

Next Article

Amarin restructures to counter downturn following Vascepa generics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Eli Lilly will ‘build new way of doing science’ in UK amid £297m pledge to government

Eli Lilly will ‘build new way of doing science’ in UK a...

Oct 18, 2024

STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more

STAT+: Pharmalittle: We’re reading about a U.S. vaccine...

Feb 9, 2024

STAT+: Remote patient monitoring helped manage hypertension better, but at a higher cost

STAT+: Remote patient monitoring helped manage hyperten...

Nov 7, 2023